How much funding has Praetego raised?

Praetego has disclosed $782.7K raised across 4 rounds.

Where is Praetego headquartered?

Praetego is headquartered in Durham, US.

Praetego

Durham, US · Founded 2017 · North Carolina corporation

Biotech

Founders & leadership

JOHN GRIFFINExecutive

PEPPER LANDSONExecutive

Board

JOHN MAZUR, MDBoard director

Reported raises · per SEC filings

Form D private placements

$782.7K disclosed across 4 rounds · 2018–2020

▶$412.7KraisedJan 2021 · 4 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

PEPPER LANDSONExecutive Officer, Director
JOHN MAZURDirector
RAJA G KHALIFAHExecutive Officer

Offering amount: $775K
Amount sold: $412.7K
First sale: Dec 2020
Incorporated: Corporation, North Carolina, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$100KraisedJan 2020 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

PEPPER LANDSONExecutive Officer, Director
JOHN MAZUR, MDDirector
JOHN GRIFFINExecutive Officer

Offering amount: $100K
Amount sold: $100K
First sale: Sep 2019
Incorporated: Corporation, North Carolina, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$250KraisedApr 2019 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

JOHN MAZUR, MDDirector
JOHN GRIFFINExecutive Officer
PEPPER LANDSONExecutive Officer, Director

Offering amount: $250K
Amount sold: $250K
First sale: Mar 2019
Incorporated: Corporation, North Carolina, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$20KraisedApr 2018 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Pepper LandsonExecutive Officer, Director
Raja KhalifahExecutive Officer, Director

Offering amount: $400K
Amount sold: $20K
Proceeds to insiders: $25K
First sale: Mar 2018
Incorporated: Corporation, North Carolina, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2023	$298.9K
National Institutes of Health (NIH)National Institutes of Health	Phase II	2022	$2.6M
National Institutes of Health (NIH)National Institutes of Health	Phase IISTTR	2020	$2.6M
National Institutes of Health (NIH)National Institutes of Health	Phase I	2018	$299.8K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Build, Grow, and Scale: How a Young Bank Brokerage Team is Achieving Their Goals in Independence - A Podcast for Financial Advisors - Diamond Consultantsdiamond-consultants.com · Jun 2024

Praetego Inc Awarded New NIH Funding to Investigate Novel Small Molecule Drug Candidates for Neurodegeneration and Alzheimer's Disease.prnewswire.com · Jun 2021

Praetego Inc Receives NIH Phase 2 STTR Funding to Advance Novel Amadorin Drug Candidates for Diabetic Peripheral Neuropathyprnewswire.com · Sep 2020

Frequently asked questions

How much funding has Praetego raised?: Praetego has disclosed $782.7K raised across 4 rounds.
Where is Praetego headquartered?: Praetego is headquartered in Durham, US.